News

Intercell receives manufacturer's licence for future commercial manufacturing of its vaccine against Japane...

Intercell receives manufacturer's licence for future commercial manufacturing of its vaccine against Japanese...

60th anniversary of Boehringer Ingelheim in Austria

60th anniversary of Boehringer Ingelheim in Austria

>> High-ranking politicians highlight the company’s importance for...

Intercell's results on a novel pneumococcal protein-based vaccine published in the Journal of Experimental ...

Intercell's results on a novel pneumococcal protein-based vaccine published in the Journal of Experimental Medicine

Marinomed Signs Collaboration with Boehringer Ingelheim for Anti-Viral Nasal Spray Against Common Cold

Marinomed Signs Collaboration with Boehringer Ingelheim for Anti-Viral Nasal Spray Against Common Cold

Intercell finalizes submission of US Biological License Application (BLA) to FDA for licensure of Japanese ...

Intercell finalizes submission of US Biological License Application (BLA) to FDA for licensure of Japanese Encephalitis...

Sanochemia: Preliminary figures for the 2006/2007 fiscal year (1. 10. 2006 - 30. 9. 2007)

Sanochemia: Preliminary figures for the 2006/2007 fiscal year (1. 10. 2006 - 30. 9. 2007)

>> Consolidation of AlcaSynn...

PHADIA invests in VBC Genomics

PHADIA Holding AB, Sweden, a global market leader in in-vitro allergy diagnostics acquires a 24.9% holding in...

Successful collaboration between U.S. army and Intercell towards a novel vaccine against Japanese Encephali...

Successful collaboration between U.S. army and Intercell towards a novel vaccine against Japanese Encephalitis for...

2 ERC grants for IMP and IMBA researchers

According to the media two Vienna based researchers receive ERC grants: Stefan Westermann (Research Institute of...

Outstanding result for Affiris Alzheimer's Vaccine in the Latest Thomson The Ones to Watch Ranking

The Alzheimer's vaccine AD01 from AFFIRIS GmbH has been listed in first place in an analysis conducted by the...

Intercell receives milestone payment from Merck & Co. Inc. triggered by initiation of Phase II clinical tri...

Intercell receives milestone payment from Merck & Co. Inc. triggered by initiation of Phase II clinical trial of...

GSK and European Foundation for the Study of Diabetes (EFSD) commit EUR 1 million to diabetes research in E...

GSK and European Foundation for the Study of Diabetes (EFSD) commit EUR 1 million to diabetes research in Europe:...